Reimagining obstructive sleep apnoea: a new era for sleep medicine

As The Lancet Respiratory Medicine marks its 10-year anniversary, the spotlight on obstructive sleep apnoea (OSA) has never been brighter. This past decade has reshaped our understanding of OSA pathophysiology and incited questions pertaining to the role of OSA therapy. As our understanding evolves, pressing questions emerge: do all OSA patients need treatment and, if so, which individuals require it most urgently? Moreover, how do different OSA treatments influence health outcomes? Researchers have made important insights into the effects of OSA therapy on patient-centred and cardiovascular outcomes, with substantial advancements in OSA classification using innovative physiological metrics and the incorporation of machine-learning algorithms and omics, paving the future for precision health in OSA.